Lung cancer remains the leading cause of cancer-related death. In addition to chest X-rays
and computerised tomography, the detection of cancer biomarkers serves as an emerging …

BACKGROUND: Therapeutic possibilities for non-small cell lung cancer (NSCLC) have
considerably increased during recent decades. OBJECTIVE: To summarize the prognostic …

By combining the photothermal properties of the 3, 3′, 5, 5′-tetramethylbenzidine
oxidation product (TMBox) with the sensitive quenching of perovskite fluorescence by …

Targeted kinase inhibitors improve the prognosis of lung cancer patients with ALK
alterations (ALK+). However, due to the emergence of acquired resistance and varied …

The diagnosis of tumor biomarkers is an attentive approach for the early detection and
treatment of cancer. However, a cost-effective, simple, rapid, selective, and sensitive method …

Carcinoembryonic antigen (CEA) is a nonspecific serum biomarker that is elevated in many
malignancies, including colorectal cancer, medullary thyroid cancer, breast cancer, and …

Ultrasensitive quantification of protein biomarkers has significant implications in disease
diagnosis. Herein, we report a fluorescent bacteria counting immunoassay (FBCIA) strategy …

Carcinoembryonic antigen (CEA) is not only used to aid the diagnosis of lung cancer, but
also help monitor recurrence and determine the prognosis of lung cancer as well as …

Purpose Machine learning models were developed and validated to identify lung
adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) using clinical factors …

Carcinoembryonic antigen (CEA) is the gold standard biomarker for the clinical diagnosis of
cancers diseases. Accurate, fast, and sensitive screening of CEA plays an important role in …